Iradimed Corp Files 8-K Amendment, Confirms Previously Filed Earnings Release

What Happened
Iradimed Corp (IRMD) filed an amendment to a previously submitted Form 8‑K on August 18, 2026 to correct the EDGAR item designation. The company says the amendment does not change, update or supplement any disclosure in the original Form 8‑K; the earnings press release previously furnished as Exhibit 99.1 remains unchanged.

Key Details

• Amendment filed on August 18, 2026 to correct the EDGAR Item designation associated with the original Form 8‑K.
• Original filing included Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits).
• No substantive changes were made to the disclosure or the earnings press release (Exhibit 99.1).
• The amendment is procedural—meant to fix filing metadata, not to alter reported results.

Why It Matters
This is a technical correction to the SEC filing record, not new financial or operational information. For investors, the key takeaway is that Iradimed’s previously reported quarterly results and related press release stand as filed; there is no update to earnings, revenue figures or other reported metrics in this amendment. The filing ensures accurate SEC disclosure indexing and improves the accessibility and compliance of the company’s prior disclosures.